L. Bosquet

731 total citations
39 papers, 419 citations indexed

About

L. Bosquet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Bosquet has authored 39 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Bosquet's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). L. Bosquet is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). L. Bosquet collaborates with scholars based in France, United States and United Kingdom. L. Bosquet's co-authors include Serge Berthoin, François-Xavier Gamelin, Georges Baquet, C Libersa, Patrick Legros, L Léger, Yves Papelier, C. Renaud-Vilmer, A. Danino and Brigitte Dréno and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and Annals of Oncology.

In The Last Decade

L. Bosquet

30 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Bosquet France	10	182	110	90	73	66	39	419
Chee-Wee Tan United Kingdom	14	103 0.6×	129 1.2×	27 0.3×	34 0.5×	138 2.1×	39	646
Erdal Aktürk Türkiye	14	349 1.9×	81 0.7×	13 0.1×	21 0.3×	55 0.8×	50	549
Irene Chung United Kingdom	13	443 2.4×	112 1.0×	13 0.1×	26 0.4×	189 2.9×	18	662
Claudio Anzà Italy	14	373 2.0×	37 0.3×	54 0.6×	12 0.2×	8 0.1×	38	489
Tim Sueselbeck Germany	17	623 3.4×	21 0.2×	12 0.1×	86 1.2×	74 1.1×	30	881
Inna Tzoran Israel	12	254 1.4×	66 0.6×	20 0.2×	4 0.1×	226 3.4×	26	519
Halil Ataş Türkiye	15	274 1.5×	64 0.6×	9 0.1×	11 0.2×	64 1.0×	53	472
Yan Hu China	13	21 0.1×	79 0.7×	11 0.1×	38 0.5×	8 0.1×	41	428
Zhoupeng Wu China	10	33 0.2×	21 0.2×	13 0.1×	13 0.2×	40 0.6×	49	301
Giuseppe Arena Italy	19	785 4.3×	25 0.2×	7 0.1×	20 0.3×	53 0.8×	87	1.1k

Countries citing papers authored by L. Bosquet

Since Specialization

Citations

This map shows the geographic impact of L. Bosquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Bosquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Bosquet more than expected).

Fields of papers citing papers by L. Bosquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Bosquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Bosquet. The network helps show where L. Bosquet may publish in the future.

Co-authorship network of co-authors of L. Bosquet

This figure shows the co-authorship network connecting the top 25 collaborators of L. Bosquet. A scholar is included among the top collaborators of L. Bosquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Bosquet. L. Bosquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chouaïd, C., D. Debieuvre, Clarisse Audigier-Valette, et al.. (2025). Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis. Frontiers in Oncology. 15. 1526931–1526931. 1 indexed citations

Chouaïd, C., L. Bosquet, Craig Knott, et al.. (2025). Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study. Lung Cancer. 203. 108548–108548.

Zemmour, Christophe, Manuel Rodrigues, Isabelle Ray‐Coquard, et al.. (2025). PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network. The Oncologist. 30(5).

Gobbini, Élisa, Mamadou Diallo, Dominique Pasquier, et al.. (2025). Clinical characteristics and management of long survivors in extensive stage small cell lung cancer. Lung Cancer. 202. 108499–108499.

Chevrier, Marion, Jean‐Sébastien Frenel, Frédéric Guyon, et al.. (2025). Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database. Gynecologic Oncology. 201. 17–25.

Courtinard, Coralie, Renaud Schiappa, F. Pilleul, et al.. (2024). Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018). SHILAP Revista de lepidopterología. 4. 100043–100043.

Epaillard, Nicolas, Amélie Lusque, William Jacot, et al.. (2024). Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort. ESMO Open. 9(5). 103447–103447. 3 indexed citations

Cabart, Mathilde, Loı̈c Mourey, Sophie C. Schneider, et al.. (2024). Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database. Journal of Geriatric Oncology. 15(7). 101819–101819.

Girard, Nicolas, L. Bosquet, Thomas Filleron, et al.. (2024). Optimizing Treatment Strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights. Cancers. 16(21). 3563–3563. 1 indexed citations

10.

Heudel, Pierre-Étienne, Anne Montfort, D. Debieuvre, et al.. (2023). Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors. Lung Cancer. 182. 107280–107280.

11.

Debieuvre, D., Xavier Quantin, Nicolas Girard, et al.. (2023). 1396P HER2 testing pattern, characteristics of locally advanced or metastatic NSCLC patients by HER2 testing in France. Annals of Oncology. 34. S799–S799. 1 indexed citations

12.

Papazyan, Tigran T., E. Martin, Patricia Pautier, et al.. (2023). 796P Initial management and long-term outcome of advanced low-grade serous ovarian cancer (LGSOC) exploring role of surgery and maintenance therapy in the French multicentre ESME database. Annals of Oncology. 34. S533–S534. 1 indexed citations

13.

Chouaïd, C., Michael Thomas, D. Debieuvre, et al.. (2022). Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts. Cancers. 14(24). 6148–6148. 3 indexed citations

14.

Farge, Dominique, L. Bosquet, Diana Kassab‐Chahmi, et al.. (2009). 2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group. Critical Reviews in Oncology/Hematology. 73(1). 31–46. 65 indexed citations

15.

Farge, Dominique, Liliana Florea, L. Bosquet, & P. Debourdeau. (2008). Traitement de la maladie thromboembolique veineuse chez le cancéreux. Pathologie Biologie. 56(4). 220–228. 1 indexed citations

16.

Gamelin, François-Xavier, et al.. (2007). Effect of Training and Detraining on Heart Rate Variability in Healthy Young Men. International Journal of Sports Medicine. 28(7). 564–570. 50 indexed citations

17.

Négrier, Sylvie, Philippe Saïag, B. Guillot, et al.. (2006). [Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)].. PubMed. 93(4). 371–84. 20 indexed citations

18.

Bourguet, P., Anne Hitzel, Gilles Houvenaeghel, D. Vinatier, & L. Bosquet. (2006). Bulletin de synthèse de veille 2005. Recommandations pour la pratique clinique : Mise à jour 2005 des recommandations pour la prise en charge des patients adultes atteints d’un mélanome cutané sans métastase à distance (Rapport abrégé). Bulletin du Cancer. 93(4). 385–390. 5 indexed citations

19.

Négrier, Sylvie, P. Saïag, B. Guillot, et al.. (2005). Recommandations pour la Pratique Clinique : Standards, Options et Recommandations 2005 pour la prise en charge des patients adultes atteints d’un mélanome cutané MO Texte court. Annales de Dermatologie et de Vénéréologie. 132(12). 79–85. 17 indexed citations

20.

Bourguet, P., M P Blanc-Vincent, A Boneu, et al.. (2003). Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002). British Journal of Cancer. 89(S1). S84–S91. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact